These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24578278)

  • 1. MR quantitative susceptibility imaging for the evaluation of iron loading in the brains of patients with β-thalassemia major.
    Qiu D; Chan GC; Chu J; Chan Q; Ha SY; Moseley ME; Khong PL
    AJNR Am J Neuroradiol; 2014 Jun; 35(6):1085-90. PubMed ID: 24578278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative T2* magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients.
    Akhlaghpoor S; Ghahari A; Morteza A; Khalilzadeh O; Shakourirad A; Alinaghizadeh MR
    Clin Neuroradiol; 2012 Sep; 22(3):211-7. PubMed ID: 22159731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemisphere, gender and age-related effects on iron deposition in deep gray matter revealed by quantitative susceptibility mapping.
    Gong NJ; Wong CS; Hui ES; Chan CC; Leung LM
    NMR Biomed; 2015 Oct; 28(10):1267-74. PubMed ID: 26313542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study.
    Manara R; Ponticorvo S; Tartaglione I; Femina G; Elefante A; Russo C; Carafa PA; Cirillo M; Casale M; Ciancio A; Di Concilio R; De Michele E; Weiskopf N; Di Salle F; Perrotta S; Esposito F
    Neuroimage Clin; 2019; 24():102058. PubMed ID: 31711032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cardiac iron load by cardiac magnetic resonance in thalassemia.
    Merchant R; Joshi A; Ahmed J; Krishnan P; Jankharia B
    Indian Pediatr; 2011 Sep; 48(9):697-701. PubMed ID: 21169646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for noninvasive measurement of tissue iron in Cooley's anemia.
    Sheth S; Tang H; Jensen JH; Altmann K; Prakash A; Printz BF; Hordof AJ; Tosti CL; Azabagic A; Swaminathan S; Brown TR; Olivieri NF; Brittenham GM
    Ann N Y Acad Sci; 2005; 1054():358-72. PubMed ID: 16339684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
    Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
    J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR imaging of spleen in beta-thalassemia major.
    Papakonstantinou O; Drakonaki EE; Maris T; Vasiliadou A; Papadakis A; Gourtsoyiannis N
    Abdom Imaging; 2015 Oct; 40(7):2777-82. PubMed ID: 26023008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major.
    Kosaryan M; Rahimi M; Darvishi-Khezri H; Gholizadeh N; Akbarzadeh R; Aliasgharian A
    Hemoglobin; 2017 May; 41(3):151-156. PubMed ID: 28762844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
    Said Othman KM; Elshazly SA; Heiba NM
    Hematology; 2014 Oct; 19(7):380-7. PubMed ID: 24225039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of susceptibility-weighted imaging to evaluate the extent of iron accumulation in the choroid plexus of patients with β-thalassaemia major.
    Hasiloglu ZI; Asik M; Ure E; Ertem F; Apak H; Albayram S
    Clin Radiol; 2017 Oct; 72(10):903.e1-903.e7. PubMed ID: 28502664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of left atrial contractile function: a herald of iron overload in patients with beta thalassemia major.
    Shabanian R; Heidari-Bateni G; Kocharian A; Mashayekhi M; Hosseinzadeh S; Kiani A; Izadyar M; Koochakzadeh L
    Pediatr Cardiol; 2010 Jul; 31(5):680-8. PubMed ID: 20383704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance screening of iron status in transfusion-dependent beta-thalassaemia patients.
    Ooi GC; Khong PL; Chan GC; Chan KN; Chan KL; Lam W; Ng I; Ha SY
    Br J Haematol; 2004 Feb; 124(3):385-90. PubMed ID: 14717788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.
    Bilgic B; Pfefferbaum A; Rohlfing T; Sullivan EV; Adalsteinsson E
    Neuroimage; 2012 Feb; 59(3):2625-35. PubMed ID: 21925274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between Dual-Energy CT and Quantitative Susceptibility Mapping in Assessing Brain Iron Deposition in Parkinson Disease.
    Chen Y; Ge M; Kang JJ; Ding YC; Chen YC; Jia ZZ
    AJNR Am J Neuroradiol; 2023 Apr; 44(4):410-416. PubMed ID: 36958800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.